Anderson-Fabry cardiomyopathy: prevalence, pathophysiology, diagnosis and treatment

Brendan N Putko1, Kevin Wen, Richard B Thompson

  • 1Division of Cardiology, Department of Medicine, Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, T6G 2S2, AB, Canada.

Heart Failure Reviews
|July 18, 2014
PubMed

Insights

Anderson-Fabry disease (AFD) is a genetic disorder causing globotriaosylceramide buildup. Early diagnosis and enzyme replacement therapy (ERT) can manage AFD cardiomyopathy, a major cause of mortality.

Area of Science:

  • Genetics
  • Biochemistry
  • Cardiology

Background:

  • Anderson-Fabry disease (AFD) is a rare X-linked lysosomal storage disorder.
  • It results from deficient alpha-galactosidase A (α-Gal A) activity, leading to globotriaosylceramide accumulation.
  • AFD cardiomyopathy is a significant cause of mortality in affected individuals.

Observation:

  • Cardiac manifestations include structural, valvular, vascular, and conduction abnormalities.
  • Prevalence studies show AFD affects diverse ethnic populations, highlighting a potential unrecognized health burden.
  • Genetic testing is crucial for diagnosing AFD, especially in women.

Findings:

  • Echocardiography with strain imaging and cardiac MRI (late enhancement, T1 mapping) are key diagnostic tools.
  • Enzyme replacement therapy (ERT) can reverse or prevent disease progression.
  • Gene therapy and molecular chaperones are emerging as novel therapeutic strategies.

Implications:

  • Anderson-Fabry cardiomyopathy is a treatable cause of heart failure if diagnosed and managed early.
  • Prompt initiation of ERT is critical for improving outcomes and preventing irreversible cardiac damage.
  • Increased awareness and screening can help identify affected individuals and reduce mortality associated with AFD.

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
813
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
786
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
801
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
936
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
746
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.6K